GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2025

Top Holdings45 positions

Checking export access…
Activity:

CVS HEALTH CORP

11.9M$809.4M19.9%$57.60+11.62%
6 qtrssince 2023-Q4
Unchanged
0

TENET HEALTHCARE CORP

3.4M$456.6M11.2%$55.85+140.84%
26 qtrssince 2018-Q4
Increased
73

GLOBAL PMTS INC

3.8M$371.5M9.1%$124.24-22.67%
18 qtrssince 2020-Q4
Decreased
0
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

14.8M$227.1M5.6%$14.50+5.98%
6 qtrssince 2023-Q4
Increased
91

ALIGHT INC

32.7M$194M4.8%$152.19-24.77%
11 qtrssince 2022-Q3
Increased
58

UNIVERSAL HLTH SVCS INC

887,370$166.7M4.1%$153.20+21.17%
10 qtrssince 2022-Q4
Increased
57

AMAZON COM INC

742,962$141.4M3.5%$168.09+13.19%
9 qtrssince 2023-Q1
Increased
91

ZOOMINFO TECHNOLOGIES INC

12.8M$127.9M3.1%$10.63-5.48%
4 qtrssince 2024-Q2
Increased
70

THE CIGNA GROUP

374,057$123.1M3.0%$230.05+38.47%
26 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

7M$118.7M2.9%$31.09-45.17%
26 qtrssince 2018-Q4
Decreased
0

US FOODS HLDG CORP

1.8M$116.9M2.9%$44.08+48.51%
14 qtrssince 2021-Q4
Increased
58

EXPEDIA GROUP INC

647,961$108.9M2.7%$119.61+39.70%
11 qtrssince 2022-Q3
Decreased
0

CORTEVA INC

1.4M$87.6M2.2%$7.61+45.20%
22 qtrssince 2019-Q4
Decreased
0
DNBDNBDelisted

DUN & BRADSTREET HLDGS INC

9.8M$87.3M2.1%——
11 qtrssince 2022-Q3
Decreased
0

AVIS BUDGET GROUP INC

1.1M$83.7M2.1%$93.09+10.46%as of Oct 16
5 qtrssince 2024-Q1
Increased
77

PAYPAL HLDGS INC

1.2M$79.4M2.0%$65.000.00%
1 qtr
New
69

CENTENE CORP DEL

1.3M$79M1.9%$60.58+0.21%
2 qtrssince 2024-Q4
Increased
48

VIATRIS INC

8.5M$74M1.8%$10.15-19.22%
6 qtrssince 2023-Q4
Decreased
0

KNIGHT-SWIFT TRANSN HLDGS IN

1.4M$61.1M1.5%$49.58-13.20%
9 qtrssince 2023-Q1
Increased
55

ELEMENT SOLUTIONS INC

2.5M$57.2M1.4%$21.03+5.75%
25 qtrssince 2019-Q1
Increased
49
$4.1B
AUM
45
Positions
Q1 2025
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+17%Q4'23$4.3B+20%Q1'24$5.1B-8%Q2'24$4.7B+0%Q3'24$4.7B-17%Q4'24$4B+2%Q1'25$4B
Activity profile
$ moved · Q1'25
New21%Increased27%Decreased42%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 years
<1Q13%1-4Q9%1-2Y11%2Y+67%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.1B across 45 positions as of Q1 2025. Top holdings: CVS (19.9%), THC (11.2%), GPN (9.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q1 2025 Summary

Active quarter - 13 new positions, 5 exits, 14 increased. Top move: TEVA (INCREASED, conviction 91). Portfolio: $4.1B across 45 positions.

Top holdings by portfolio weight

Total AUM$4B
CVS19.90%
THC11.23%
GPN9.13%
TEVA5.58%
ALIT4.77%
UHS4.10%
AMZN3.48%
GTM3.14%
CI3.03%
DXC2.92%
Other2.87%

Portfolio allocation by GICS sector

Sectors9
Healthcare51.57%
Industrials13.86%
Technology13.65%
Consumer Cyclical7.81%
Basic Materials3.76%
Consumer Defensive2.89%
Communication Services2.35%
Unknown2.16%
Financial Services1.96%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Industrials, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L64
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PMTS INC
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON COM INC
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENational Vision Holdings Inc
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used